Midterm Clinical Outcomes, Radiographic Outcomes, and Survivorship of the Infinity Total Ankle Arthroplasty
Foot & Ankle International · 2023
DOI: 10.1177/10711007231201136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Foot & Ankle International, 2023. Verfasst von Isabel Shaffrey und 7 weiteren Autor:innen. Beteiligte Einrichtung: Foot & Ankle Department, Hospital for Special Surgery, New York, NY, USA. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Ankle, Joint Prosthesis, Cysts. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
The Infinity Total Ankle Arthroplasty (Stryker, Mahwah, NJ) is a low-profile fixed-bearing implant first introduced in 2014. Although the short-term survivorship (2-4 years follow-up) and complication rates of the Infinity TAA have been reported, there are limited midterm outcome reports. The aim of this study was to describe the survivorship and clinical outcomes of a single-center experience with the Infinity implant at minimum 5-year follow-up.
Methods
Retrospective review of 65 ankles that underwent primary total ankle arthroplasty (TAA) with the Infinity implant was conducted. Mean clinical follow-up was 6.5 years (range, 5.0-8.0). Preoperative and postoperative radiographs were measured to assess tibiotalar alignment, periprosthetic lucencies, and cysts. Preoperative, 2-year, and 5-year postoperative Foot and Ankle Outcome Score (FAOS) subscores were compared to assess midterm clinical outcomes. Survivorship assessment was determined by removal of 1 or both metallic implant components.
Results
Survivorship of the implant was 93.8% at final follow-up. There were 4 revisions: 2 for tibial implant loosening, 1 for talar loosening, and 1 for loosening of both components. Three of the 4 revisions occurred within the first 2 years following implantation, and the last failure occurred at 7 years postoperatively. There were 11 reoperations in 10 (15%) ankles and 3 wound complications. There were 17 ankles (26.2%) with radiographic abnormalities around the implants, including 14 cases with tibial component lucencies and 4 cases of periimplant cysts. FAOS outcome measurement showed general stability between 2 and 5 years and substantial improvement from preoperative status.
Conclusion
To date this study is the largest midterm report on the Infinity total ankle prosthesis, with 65 implants at a mean follow-up of 6.5 years. We found good midterm implant survivorship, and patients experienced significant improvements in FAOS outcome scores and radiographic alignment at final follow-up. Level of Evidence: Level III, retrospective cohort study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Foot & Ankle Department, Hospital for Special Surgery, New York, NY, USA.
ORCID-Profile: Isabel Shaffrey, Lavan Rajan, Scott J Ellis
Zitieren
APA
Shaffrey, I., O'Malley, E., Henry, J. K., Rajan, L., Deland, J. T., O'Malley, M., Ellis, S. J., & Demetracopoulos, C. A. (2023). Midterm Clinical Outcomes, Radiographic Outcomes, and Survivorship of the Infinity Total Ankle Arthroplasty. Foot & Ankle International. https://doi.org/10.1177/10711007231201136
Vancouver
Shaffrey I, O'Malley E, Henry JK, Rajan L, Deland JT, O'Malley M, et al. Midterm Clinical Outcomes, Radiographic Outcomes, and Survivorship of the Infinity Total Ankle Arthroplasty. Foot & Ankle International. 2023. doi:10.1177/10711007231201136
BibTeX
@article{Shaffrey2023,
author = {Shaffrey, Isabel and O'Malley, Emmett and Henry, Jensen K and Rajan, Lavan and Deland, Jonathan T and O'Malley, Martin and Ellis, Scott J and Demetracopoulos, Constantine A},
title = {Midterm Clinical Outcomes, Radiographic Outcomes, and Survivorship of the Infinity Total Ankle Arthroplasty},
journal = {Foot & Ankle International},
year = {2023},
doi = {10.1177/10711007231201136}
}
EUVIMED